Baolingbao Biology Co.,Ltd. (002286.SZ)
CNY 7.94
(-1.24%)
CNY 7.94
(-1.24%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.65 Billion CNY | -11.55% |
| 2022 | 3 Billion CNY | -0.75% |
| 2021 | 3.02 Billion CNY | 15.8% |
| 2020 | 2.61 Billion CNY | 3.85% |
| 2019 | 2.51 Billion CNY | -2.35% |
| 2018 | 2.57 Billion CNY | 22.42% |
| 2017 | 2.1 Billion CNY | 9.08% |
| 2016 | 1.93 Billion CNY | 0.94% |
| 2015 | 1.91 Billion CNY | 8.35% |
| 2014 | 1.76 Billion CNY | 5.36% |
| 2013 | 1.67 Billion CNY | 50.63% |
| 2012 | 1.11 Billion CNY | 0.02% |
| 2011 | 1.11 Billion CNY | 7.75% |
| 2010 | 1.03 Billion CNY | -4.75% |
| 2009 | 1.08 Billion CNY | 45.73% |
| 2008 | 743.9 Million CNY | 23.59% |
| 2007 | 601.89 Million CNY | 18.5% |
| 2006 | 507.93 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2.67 Billion CNY | -1.15% |
| 2024 Q1 | 2.65 Billion CNY | -0.2% |
| 2024 Q2 | 2.7 Billion CNY | 2.05% |
| 2023 Q2 | 2.92 Billion CNY | -2.47% |
| 2023 Q4 | 2.65 Billion CNY | -3.61% |
| 2023 Q1 | 3 Billion CNY | -0.09% |
| 2023 FY | 2.65 Billion CNY | -11.55% |
| 2023 Q3 | 2.75 Billion CNY | -5.83% |
| 2022 Q2 | 3 Billion CNY | 3.27% |
| 2022 Q4 | 3 Billion CNY | 4.85% |
| 2022 Q3 | 2.86 Billion CNY | -4.74% |
| 2022 FY | 3 Billion CNY | -0.75% |
| 2022 Q1 | 2.91 Billion CNY | -3.78% |
| 2021 Q1 | 2.8 Billion CNY | 7.34% |
| 2021 FY | 3.02 Billion CNY | 15.8% |
| 2021 Q4 | 3.02 Billion CNY | 4.0% |
| 2021 Q3 | 2.91 Billion CNY | 1.15% |
| 2021 Q2 | 2.87 Billion CNY | 2.55% |
| 2020 Q4 | 2.61 Billion CNY | 4.89% |
| 2020 Q2 | 2.57 Billion CNY | -1.84% |
| 2020 Q3 | 2.49 Billion CNY | -3.09% |
| 2020 FY | 2.61 Billion CNY | 3.85% |
| 2020 Q1 | 2.62 Billion CNY | 4.07% |
| 2019 Q4 | 2.51 Billion CNY | -2.39% |
| 2019 Q2 | 2.76 Billion CNY | 2.25% |
| 2019 FY | 2.51 Billion CNY | -2.35% |
| 2019 Q1 | 2.7 Billion CNY | 4.98% |
| 2019 Q3 | 2.58 Billion CNY | -6.79% |
| 2018 Q4 | 2.57 Billion CNY | 4.54% |
| 2018 Q3 | 2.46 Billion CNY | -3.63% |
| 2018 Q2 | 2.56 Billion CNY | 11.78% |
| 2018 FY | 2.57 Billion CNY | 22.42% |
| 2018 Q1 | 2.29 Billion CNY | 8.71% |
| 2017 Q1 | 1.94 Billion CNY | 0.72% |
| 2017 FY | 2.1 Billion CNY | 9.08% |
| 2017 Q3 | 2.01 Billion CNY | 1.23% |
| 2017 Q2 | 1.99 Billion CNY | 2.34% |
| 2017 Q4 | 2.1 Billion CNY | 4.54% |
| 2016 FY | 1.93 Billion CNY | 0.94% |
| 2016 Q4 | 1.93 Billion CNY | 1.08% |
| 2016 Q3 | 1.91 Billion CNY | -0.08% |
| 2016 Q2 | 1.91 Billion CNY | -0.14% |
| 2016 Q1 | 1.91 Billion CNY | 0.08% |
| 2015 Q1 | 1.87 Billion CNY | 6.0% |
| 2015 FY | 1.91 Billion CNY | 8.35% |
| 2015 Q4 | 1.91 Billion CNY | 2.95% |
| 2015 Q2 | 1.93 Billion CNY | 3.33% |
| 2015 Q3 | 1.85 Billion CNY | -3.9% |
| 2014 Q3 | 1.69 Billion CNY | 1.55% |
| 2014 FY | 1.76 Billion CNY | 5.36% |
| 2014 Q4 | 1.76 Billion CNY | 4.14% |
| 2014 Q2 | 1.66 Billion CNY | -0.73% |
| 2014 Q1 | 1.68 Billion CNY | 0.36% |
| 2013 Q2 | 1.69 Billion CNY | 49.21% |
| 2013 Q3 | 1.66 Billion CNY | -1.47% |
| 2013 Q4 | 1.67 Billion CNY | 0.41% |
| 2013 FY | 1.67 Billion CNY | 50.63% |
| 2013 Q1 | 1.13 Billion CNY | 2.04% |
| 2012 Q3 | 1.11 Billion CNY | -3.39% |
| 2012 Q1 | 1.1 Billion CNY | -1.11% |
| 2012 Q2 | 1.15 Billion CNY | 5.16% |
| 2012 Q4 | 1.11 Billion CNY | -0.45% |
| 2012 FY | 1.11 Billion CNY | 0.02% |
| 2011 Q4 | 1.11 Billion CNY | 2.47% |
| 2011 Q1 | 1.07 Billion CNY | 4.4% |
| 2011 Q2 | 1.08 Billion CNY | 1.07% |
| 2011 FY | 1.11 Billion CNY | 7.75% |
| 2011 Q3 | 1.08 Billion CNY | -0.36% |
| 2010 Q1 | 1.15 Billion CNY | 6.75% |
| 2010 Q4 | 1.03 Billion CNY | -5.31% |
| 2010 FY | 1.03 Billion CNY | -4.75% |
| 2010 Q3 | 1.09 Billion CNY | 0.67% |
| 2010 Q2 | 1.08 Billion CNY | -6.41% |
| 2009 Q2 | 778.69 Million CNY | 0.0% |
| 2009 Q3 | 1.24 Billion CNY | 60.08% |
| 2009 Q4 | 1.08 Billion CNY | -13.03% |
| 2009 FY | 1.08 Billion CNY | 45.73% |
| 2008 FY | 743.9 Million CNY | 23.59% |
| 2008 Q4 | 743.9 Million CNY | 0.0% |
| 2007 FY | 601.89 Million CNY | 18.5% |
| 2006 FY | 507.93 Million CNY | 0.0% |